Xylem Financial Statements (XYL) |
||||||||||
Xylemsmart-lab.ru | % | 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
---|---|---|---|---|---|---|---|---|---|---|
Report date | 04.08.2023 | 31.10.2023 | 31.12.2023 | 28.02.2024 | 02.05.2024 | 02.05.2024 | ||||
Currency | USD | USD | USD | USD | USD | USD | ||||
Financial report URL | ||||||||||
Revenue, bln rub | ? | 1 722 | 2 076 | 2 118 | 2 119 | 0.000 | 6 313 | |||
Operating Income, bln rub | 119.0 | 152.0 | 266.0 | 233.0 | 153.0 | 804.0 | ||||
EBITDA, bln rub | ? | 246.0 | 152.0 | 266.0 | 370.0 | 153.0 | 941.0 | |||
Net profit, bln rub | ? | 92.0 | 152.0 | 266.0 | 266.0 | 153.0 | 837.0 | |||
OCF, bln rub | ? | 28.0 | 373.0 | 455.0 | 455.0 | 1 283 | ||||
CAPEX, bln rub | ? | 54.0 | 74.0 | 94.0 | 94.0 | 262.0 | ||||
FCF, bln rub | ? | -26.0 | 299.0 | 361.0 | 361.0 | 1 021 | ||||
Dividend payout, bln rub | 79.0 | 80.0 | 80.0 | 80.0 | 240.0 | |||||
Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |||||
Dividend payout ratio, % | 85.9% | 52.6% | 30.1% | 30.1% | 0.00% | 28.7% | ||||
OPEX, bln rub | 504.0 | 552.0 | 1 852 | 526.0 | 0.000 | 2 930 | ||||
Cost of production, bln rub | 1 071 | 1 312 | 0.000 | 1 360 | 0.000 | 2 672 | ||||
R&D, bln rub | 58.0 | 61.0 | 0.000 | 60.0 | 0.000 | 121.0 | ||||
Interest expenses, bln rub | 12.0 | 14.0 | 0.000 | 21.0 | 0.000 | 35.0 | ||||
Assets, bln rub | 16 097 | 15 905 | 16 112 | 16 112 | 15 924 | 15 924 | ||||
Net Assets, bln rub | ? | 9 899 | 9 930 | 10 166 | 10 166 | 10 195 | 10 195 | |||
Debt, bln rub | 2 267 | 2 270 | 2 284 | 2 662 | 2 270 | 2 270 | ||||
Cash, bln rub | 708.0 | 705.0 | 1 019 | 1 019 | 947.0 | 947.0 | ||||
Net debt, bln rub | 1 559 | 1 565 | 1 265 | 1 643 | 1 323 | 1 323 | ||||
Ordinary share price, rub | 112.6 | 91.0 | 114.4 | 114.4 | 94.3 | |||||
Number of ordinary shares, mln | 205.5 | 240.9 | 242.5 | 241.5 | 241.8 | 241.8 | ||||
Market cap, bln rub | 23 148 | 21 926 | 27 732 | 27 618 | 0 | 22 802 | ||||
EV, bln rub | ? | 24 707 | 23 491 | 28 997 | 29 261 | 1 323 | 24 125 | |||
Book value, bln rub | -397 | -258 | 2 579 | 50 | 232 | 232 | ||||
EPS, rub | ? | 0.45 | 0.63 | 1.10 | 1.10 | 0.63 | 3.46 | |||
FCF/share, rub | -0.13 | 1.24 | 1.49 | 1.49 | 0.00 | 4.22 | ||||
BV/share, rub | -1.93 | -1.07 | 10.6 | 0.21 | 0.96 | 0.96 | ||||
EBITDA margin, % | ? | 14.3% | 7.32% | 12.6% | 17.5% | 14.9% | ||||
Net margin, % | ? | 5.34% | 7.32% | 12.6% | 12.6% | 13.3% | ||||
FCF yield, % | ? | 1.54% | 2.31% | 2.04% | 2.05% | 4.48% | ||||
ROE, % | ? | 3.56% | 4.95% | 5.99% | 5.99% | 6.50% | 8.21% | |||
ROA, % | ? | 2.19% | 3.09% | 3.78% | 3.78% | 4.16% | 5.26% | |||
P/E | ? | 65.8 | 44.6 | 45.5 | 45.4 | 0.00 | 27.2 | |||
P/FCF | 64.8 | 43.2 | 49.0 | 48.8 | 0.00 | 22.3 | ||||
P/S | ? | 3.82 | 3.25 | 3.77 | 3.75 | 0.00 | 3.61 | |||
P/BV | ? | -58.3 | -85.0 | 10.8 | 552.4 | 0.00 | 98.3 | |||
EV/EBITDA | ? | 30.1 | 27.0 | 33.4 | 30.1 | 1.44 | 25.6 | |||
Debt/EBITDA | 1.90 | 1.80 | 1.46 | 1.69 | 1.44 | 1.41 | ||||
R&D/CAPEX, % | 107.4% | 82.4% | 0.00% | 63.8% | 46.2% | |||||
CAPEX/Revenue, % | 3.14% | 3.56% | 4.44% | 4.44% | 4.15% | |||||
Xylem shareholders |